CUE-101
cue biopharma
['headandneck', 'cue bio', 'cuebio']
today at the annual meeting dr. christine chung, m.d. presented a poster highlighting positive phase 1 data supporting the therapeutic potential of our lead il-2-based biologic for the treatment of recurrent/metastatic #headandneckcancer. learn more: 
Developing novel injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body.